T. Rowe Price Associates’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-133,037
| Closed | -$3.06M | – | 3051 |
|
|
2021
Q3 | $3.06M | Sell |
133,037
-1,249
| -0.9% | -$28.7K | ﹤0.01% | 1600 |
|
|
2021
Q2 | $5.9M | Sell |
134,286
-667
| -0.5% | -$29.3K | ﹤0.01% | 1481 |
|
|
2021
Q1 | $9.8M | Sell |
134,953
-131
| -0.1% | -$9.51K | ﹤0.01% | 1396 |
|
|
2020
Q4 | $5.84M | Sell |
135,084
-174,233
| -56% | -$7.53M | ﹤0.01% | 1421 |
|
|
2020
Q3 | $12.7M | Sell |
309,317
-181,995
| -37% | -$7.48M | ﹤0.01% | 1246 |
|
|
2020
Q2 | $29.5M | Buy |
491,312
+55,642
| +13% | +$3.34M | ﹤0.01% | 1019 |
|
|
2020
Q1 | $32.8M | Sell |
435,670
-111,276
| -20% | -$8.38M | 0.01% | 916 |
|
|
2019
Q4 | $75.2M | Buy |
546,946
+51,478
| +10% | +$7.08M | 0.01% | 763 |
|
|
2019
Q3 | $58.9M | Buy |
495,468
+90,812
| +22% | +$10.8M | 0.01% | 805 |
|
|
2019
Q2 | $56.6M | Buy |
404,656
+201,587
| +99% | +$28.2M | 0.01% | 837 |
|
|
2019
Q1 | $36.3M | Buy |
203,069
+11,916
| +6% | +$2.13M | 0.01% | 987 |
|
|
2018
Q4 | $30.1M | Buy |
+191,153
| New | +$30.1M | 0.01% | 1000 |
|